Successful New Treatment For Hodgkin's Lymphoma, Reduces Long-term Risks

A new chemotherapy regimen for pediatric Hodgkin's lymphoma patients has been identified. The new treatment enhances efficacy through dose-dense drug delivery while simultaneously reducing the long-term risks presented by high cumulative dose chemotherapy.

Read the whole article on Science Daily

More from Science Daily